Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug 13:6:203.
doi: 10.3389/fnagi.2014.00203. eCollection 2014.

β-amyloid in biological samples: not all Aβ detection methods are created equal

Paul A Adlard  1 , Qiao-Xin Li  2 , Catriona McLean  1 , Colin L Masters  1 , Ashley I Bush  1 , Michelle Fodero-Tavoletti  3 , Victor Villemagne  1 , Kevin J Barnham  4
Affiliations

β-amyloid in biological samples: not all Aβ detection methods are created equal

Paul A Adlard et al. Front Aging Neurosci. .
No abstract available

Keywords: ELISA; amyloid; detection; mass spectrometry; western blot.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Levels of Aβ detected in brain homogenates from a common set of human cases. (A,B) Western blot assessment of soluble and insoluble Aβ burden across the entire cohort of neurological cases and healthy control cases utilized in this study (C–F) ELISA assessment of soluble and insoluble Aβ burden across the entire cohort of neurological cases and healthy control cases utilized in this study (G) A comparison of SELDI mass spectrometric and ELISA assessment of Aβ burden (Aβ 1-40 and Aβ 1-42) across a subset of the cases examined in this study. *p < 0.05; **p < 0.01.
See this image and copyright information in PMC

References

    1. Adlard P. A., Cherny R. A., Finkelstein D. I., Gautier E., Robb E., Cortes M., et al. (2008). Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 59, 43–55 10.1016/j.neuron.2008.06.018 - DOI - PubMed
    1. Adlard P. A., Cummings B. J. (2004). Alzheimer's disease–a sum greater than its parts? Neurobiol. Aging 25, 725–733 discussion 743–726. 10.1016/j.neurobiolaging.2003.12.016 - DOI - PubMed
    1. Bjerke M., Portelius E., Minthon L., Wallin A., Anckarsäter H., Anckarsäter R., et al. (2010). Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid. Int. J. Alzheimer's Dis. 2010:986310 10.4061/2010/986310 - DOI - PMC - PubMed
    1. Hardy J., Selkoe D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353–356 10.1126/science.1072994 - DOI - PubMed
    1. Karran E., Mercken M., De Strooper B. (2011). The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat. Rev. Drug Discov. 10, 698–712 10.1038/nrd3505 - DOI - PubMed

LinkOut - more resources